Sanara MedTech (SMTI) Equity Ratio (2010 - 2026)

Sanara MedTech has reported Equity Ratio for 15 years, with the latest figure at 0.1 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio fell 73.33% year-over-year to 0.1; the trailing twelve-month figure through Mar 2026 stood at 0.1 (down 73.33% YoY), and the FY2025 full-year result was 0.08, down 81.6% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.1, up from 0.08 in the prior quarter.
• The five-year high for Equity Ratio was 0.85 in Q2 2022, with the low at 0.08 in Q4 2025.
• Historically, Equity Ratio has averaged 0.51 across 5 years, with a median of 0.56 in 2024.
• Annual changes were most pronounced in 2024 — Equity Ratio advanced 1.74% — and 2025, when it sank 81.6%.
• Sanara MedTech's Equity Ratio stood at 0.68 in 2022, then decreased by 11.7% to 0.6 in 2023, then declined by 26.82% to 0.44 in 2024, then slumped by 81.6% to 0.08 in 2025, then increased by 24.8% to 0.1 in 2026.
• The last three Equity Ratio figures came in at 0.1 (Q1 2026), 0.08 (Q4 2025), and 0.09 (Q3 2025), per Business Quant data.